| 12/08/25 | 12:00:01 | 12 Aug 2025 | | PRTC Launches Celea to Advance Ph3-Ready IPF Drug |
| 05/08/25 | 17:30:01 | 5 Aug 2025 | | Holding(s) in Company |
| 01/08/25 | 07:00:09 | 1 Aug 2025 | | Total Voting Rights |
| 17/07/25 | 12:05:00 | 17 Jul 2025 | | PRTC’s Seaport Begins Phase 2b Study in MDD |
| 16/07/25 | 07:00:08 | 16 Jul 2025 | | PureTech Announces Leadership Transition |
| 08/07/25 | 17:45:00 | 8 Jul 2025 | | Directorate Change |
| 04/07/25 | 17:30:00 | 4 Jul 2025 | | PDMR Notification |
| 04/07/25 | 17:30:00 | 4 Jul 2025 | | PDMR Notification RSU Vesting |
| 04/07/25 | 17:30:00 | 4 Jul 2025 | | PDMR Notification RSU Vesting |
| 01/07/25 | 07:00:07 | 1 Jul 2025 | | Total Voting Rights |
| 26/06/25 | 07:00:11 | 26 Jun 2025 | | PRTC'S Vor Announces RemeGen License & $175M PIPE |
| 16/06/25 | 17:27:40 | 16 Jun 2025 | | Result of AGM |
| 29/05/25 | 17:30:00 | 29 May 2025 | | Holding(s) in Company |
| 22/05/25 | 12:00:00 | 22 May 2025 | | PRTC to Present at Jefferies Healthcare Conference |
| 21/05/25 | 07:00:10 | 21 May 2025 | | PRTC: IPF Data Support Lung Function Stabilization |
| 09/05/25 | 12:00:01 | 9 May 2025 | | PRTC Publishes Research on Unmet IPF Patient Needs |
| 01/05/25 | 12:00:01 | 1 May 2025 | | PRTC To Present Ph2b IPF Results at ATS Conference |
| 30/04/25 | 07:00:07 | 30 Apr 2025 | | Final Results |
| 23/04/25 | 07:00:09 | 23 Apr 2025 | | Notice of Results |
| 11/04/25 | 07:00:09 | 11 Apr 2025 | | Holding(s) in Company |
| 09/04/25 | 15:00:43 | 9 Apr 2025 | | Form 8.3 PURETECH HEALTH PLC |
| 09/04/25 | 07:00:12 | 9 Apr 2025 | | PRTC Appoints Peel Hunt Joint UK Corporate Broker |
| 08/04/25 | 13:15:06 | 8 Apr 2025 | | Form 8.3 -PURETECH HEALTH PLC |
| 08/04/25 | 13:10:55 | 8 Apr 2025 | | Form 8.3 PURETECH HEALTH PLC |
| 08/04/25 | 10:00:27 | 8 Apr 2025 | | Form 8.3 - Puretech Health plc |
| 07/04/25 | 17:22:29 | 7 Apr 2025 | | Rule 2.8 Announcement |
| 07/04/25 | 16:27:02 | 7 Apr 2025 | | Statement re Possible Offer |
| 11/03/25 | 11:05:00 | 11 Mar 2025 | | PRTC's Seaport Adds Finance/Operations Exec to BOD |
| 03/03/25 | 07:00:04 | 3 Mar 2025 | | Total Voting Rights |
| 27/02/25 | 17:30:00 | 27 Feb 2025 | | PDMR Notification RSU Vesting |
| 25/02/25 | 12:00:01 | 25 Feb 2025 | | PRTC Presents at Leerink Partners Healthcare Conf |
| 12/02/25 | 12:05:00 | 12 Feb 2025 | | PRTC's Seaport Publishes New Glyph Platform Data |
| 27/01/25 | 07:00:08 | 27 Jan 2025 | | PRTC's Vedanta Publishes Ph2 in Nature Medicine |
| 09/01/25 | 12:00:01 | 9 Jan 2025 | | PRTC's LYT-200 Gets Fast Track Designation in AML |
| 08/01/25 | 12:00:00 | 8 Jan 2025 | | PureTech to Present at the JP Morgan Conference |
| 06/01/25 | 07:00:05 | 6 Jan 2025 | | PureTech Appoints UBS as UK Corporate Broker |
| 16/12/24 | 07:00:05 | 16 Dec 2024 | | PRTC's Ph2b in IPF Successful; New SOC Potential |
| 11/12/24 | 17:30:00 | 11 Dec 2024 | | Holding(s) in Company |
| 11/12/24 | 12:05:00 | 11 Dec 2024 | | PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP |
| 09/12/24 | 07:00:07 | 9 Dec 2024 | | PRTC Presents LYT-200 Phase 1b Data in AML at ASH |
| 27/11/24 | 17:31:00 | 27 Nov 2024 | | Holding(s) in Company |
| 27/11/24 | 17:30:00 | 27 Nov 2024 | | Holding(s) in Company |
| 20/11/24 | 12:05:00 | 20 Nov 2024 | | PRTC's Seaport Adds Microsoft and J&J Exec to BOD |
| 05/11/24 | 12:05:00 | 5 Nov 2024 | | PRTC's Seaport Adds Biotech Finance Exec as CFO |
| 01/11/24 | 07:00:02 | 1 Nov 2024 | | Total Voting Rights |
| 31/10/24 | 17:00:01 | 31 Oct 2024 | | Director/PDMR Shareholding |
| 30/10/24 | 11:00:00 | 30 Oct 2024 | | PRTC to Present at UBS and Jefferies Conferences |
| 21/10/24 | 07:00:04 | 21 Oct 2024 | | PRTC's Seaport Closes $225M Series B Financing |
| 09/10/24 | 07:00:06 | 9 Oct 2024 | | PRTC's IPF Patient Research & Ph 2b On Track YE24 |
| 01/10/24 | 12:00:01 | 1 Oct 2024 | | PRTC to Give 3 Presentations at CHEST 2024 Meeting |
